Halozyme Therapeutics
HALO
#1865
Rank
โ‚น1.025 T
Marketcap
โ‚น8,994
Share price
0.30%
Change (1 day)
43.81%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): โ‚น329.41

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is โ‚น328.91. In 2025 the company made an earnings per share (EPS) of โ‚น243.88 a decrease over its 2024 EPS that were of โ‚น327.04.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น329.4135.07%
2025โ‚น243.88-25.43%
2024โ‚น327.04
2022โ‚น138.29-48.07%
2021โ‚น266.30196.88%
2020โ‚น89.70-292%
2019-โ‚น46.72-9.09%
2018-โ‚น51.39-237.5%
2017โ‚น37.38-149.38%
2016-โ‚น75.69211.54%
2015-โ‚น24.29-52.73%
2014-โ‚น51.39-24.66%
2013-โ‚น68.2148.98%
2012-โ‚น45.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น624.16 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น66.34-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,886 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น185.06-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น131.75-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚น12.15-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA